MaxCyte’s Scientific Advisory Board will provide guidance to shape the technical direction of the company’s innovation initiatives focused on the discovery, development and manufacturing of next-generation, cell-based medicines. ROCKVILLE, MD — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to […]
Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD Detection FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the launch of a new 20-Color Acute Myeloid Leukemia (AML) Panel. A new single-tube flow panel for the development of AML therapies, this pre-optimized […]
San Diego, CA – In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, have announced plans for a supply agreement with the Center for […]
LEIDEN, the Netherlands — MIMETAS, a leading company in the field of organ-on-a-chip-based disease models, announces that it has launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format. As part of its OrganoReady® product line, MIMETAS offers two organoid-based products: ASC-derived Colon1 and Kidney2 Organoid tubules. “We are thrilled to offer this cutting-edge technology to the research […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. The multi-year partnership aims to develop new technologies that will improve the consistency of clinical outcomes for patients and overcome manufacturing bottlenecks in the delivery of next generation engineered […]
EPPENDORF SELLS ITS MICRO MANIPULATION PRODUCT PORTFOLIO TO A GERMAN SUBSIDIARY OF CALIBRE SCIENTIFIC Eppendorf divests micro manipulation product portfolio > Eppendorf sells its micro manipulation product portfolio to a German subsidiary of Calibre Scientific > Divestment enables focus on the Group’s core products Hamburg, March 6, 2023 – The globally active Eppendorf Group has […]
Eppendorf sells its micro manipulation product portfolio to a German subsidiary of Calibre Scientific Divestment enables focus on the Group’s core businesses Hamburg – The globally active Eppendorf Group has divested its micro manipulation product portfolio to Calibre Scientific GmbH in Hamburg, Germany. Calibre Scientific GmbH is part of the U.S.-based global life sciences company […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target of $55 million, triggering Bio-Techne’s initial investment in the company, which is expected to close at the end of March 2023. Bio-Techne’s $257 million investment will give the Company a 20% ownership […]
SALUGGIA, Italy, and FREMONT, Calif. — DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit to Cytek for approximately USD 46.5 million. The decision to […]
Araceli Biosciences Unveils New Cutting-Edge Headquarters to Fuel Scientific Innovation and Growth Hillsboro, OR – Araceli Biosciences, a leading biotechnology company, has announced its relocation to a new, larger headquarters location to accommodate expanding operations and better serve customers. Araceli will be moving to Tech Center Drive in Tigard, OR, located near the intersection of […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
